Focus: iotaMotion develops robotic-assisted insertion systems for cochlear implants, addressing precision and safety in hearing restoration surgery. The company operates as a public medical device manufacturer focused on a high-acuity surgical niche.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
High-potential medtech innovator with meaningful clinical impact but early commercialization stage and opaque fundamentals—best for specialists willing to bet on robotics-assisted surgery adoption.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for iotaMotion
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from iotaMotion's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moRecent peer-reviewed publications with author affiliations at this company
Robotic assistance during cochlear implantation: the rationale for consistent, controlled speed of electrode array insertion.
A Steadier Hand: The First Human Clinical Trial of a Single-Use Robotic-Assisted Surgical Device for Cochlear Implant Electrode Array Insertion.
Showing 5 of 7 publications